A U of A researcher recently created a new class of drugs that targets and kills cancer cells with less damage to healthy ...
The ADC payload landscape is shifting rapidly. Driven by clinical successes of lower potency topoisomerase I inhibitors and as payloads that elicit novel modes of action continue to gain momentum ...
Which of the statements about the diagnosis and management of difficult-to-treat rheumatoid arthritis are correct?
Continuous development and commercialisation of the company's proprietary innovative technologies with global partners to generate value through sustainable production of battery materials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback